Fei Hu

975 total citations
29 papers, 828 citations indexed

About

Fei Hu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Fei Hu has authored 29 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Fei Hu's work include Autophagy in Disease and Therapy (8 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Electric and Hybrid Vehicle Technologies (3 papers). Fei Hu is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Electric and Hybrid Vehicle Technologies (3 papers). Fei Hu collaborates with scholars based in China, Norway and United States. Fei Hu's co-authors include Xiaojun Yan, Congcong Liu, Xiaowei Yang, Guohua Gao, Guangming Wu, Xianling Guo, Qing Xu, Lixin Wei, Shanshan Zhang and Mengchao Wu and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Fei Hu

27 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Hu China 13 303 261 222 194 146 29 828
Guanwu Li China 19 349 1.2× 181 0.7× 82 0.4× 445 2.3× 154 1.1× 40 1.1k
Qiaoxia Zhang China 21 684 2.3× 42 0.2× 140 0.6× 79 0.4× 293 2.0× 51 1.2k
Guangjie Yang China 14 229 0.8× 28 0.1× 180 0.8× 130 0.7× 32 0.2× 43 821
Chengwu Tang China 15 232 0.8× 48 0.2× 35 0.2× 211 1.1× 156 1.1× 34 826
Xiaoxiao Peng China 18 393 1.3× 49 0.2× 22 0.1× 169 0.9× 176 1.2× 38 885
Huijin Li China 16 337 1.1× 50 0.2× 45 0.2× 222 1.1× 258 1.8× 47 809
Qidong Li China 16 471 1.6× 28 0.1× 174 0.8× 802 4.1× 357 2.4× 25 1.6k
Yawen Guo China 18 326 1.1× 77 0.3× 19 0.1× 141 0.7× 126 0.9× 51 1.0k
Yingying Li China 20 821 2.7× 65 0.2× 44 0.2× 40 0.2× 165 1.1× 60 1.1k

Countries citing papers authored by Fei Hu

Since Specialization
Citations

This map shows the geographic impact of Fei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Hu more than expected).

Fields of papers citing papers by Fei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Hu. The network helps show where Fei Hu may publish in the future.

Co-authorship network of co-authors of Fei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Hu. A scholar is included among the top collaborators of Fei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Hu. Fei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Fei, et al.. (2025). BFGF downregulates endoplasmic reticulum stress to alleviate HUVEC cell damage under high-glucose and inflammatory conditions. Endokrynologia Polska. 76(3). 290–300. 1 indexed citations
2.
3.
Li, Li & Fei Hu. (2024). The correlation between S-nitrosylation and type 2 diabetes mellitus: a review. Endokrynologia Polska. 75(5). 473–478. 1 indexed citations
4.
Chen, Junyu, et al.. (2021). Clinical characteristics and outcomes of primary intracranial alveolar soft-part sarcoma: A case report. World Journal of Clinical Cases. 10(1). 296–303.
5.
Fang, Juemin, Zhongzheng Zhu, Hui Wang, et al.. (2018). The establishment of a new medical model for tumor treatment combined with Watson for Oncology, MDT and patient involvement.. Journal of Clinical Oncology. 36(15_suppl). e18504–e18504. 4 indexed citations
6.
Gao, Song, et al.. (2018). Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR‐381/CXCR4 axis. Journal of Cellular Physiology. 234(5). 6746–6757. 31 indexed citations
7.
Hu, Fei, Xianling Guo, Shanshan Zhang, et al.. (2017). Suppression of p53 potentiates chemosensitivity in nutrient-deprived cholangiocarcinoma cells via inhibition of autophagy. Oncology Letters. 14(2). 1959–1966. 14 indexed citations
8.
Hu, Fei, Yi Yu, Juemin Fang, et al.. (2017). Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3. Cancer Letters. 416. 24–30. 55 indexed citations
9.
Yuan, Yan, Yi Wang, Fei Hu, et al.. (2016). Cadmium Activates Reactive Oxygen Species-dependent AKT/mTOR and Mitochondrial Apoptotic Pathways in Neuronal Cells.. PubMed. 29(2). 117–26. 47 indexed citations
10.
Hu, Fei, et al.. (2015). A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma. Drug Design Development and Therapy. 9. 3625–3625. 19 indexed citations
11.
Liu, Zhuqing, Yingchao Han, Juemin Fang, et al.. (2015). WITHDRAWN: Hypoxia-induced STAT3 contributes to chemoresistance and epithelial–mesenchymal transition in prostate cancer cells. Biochemical and Biophysical Research Communications. 3 indexed citations
12.
Liu, Zhuqing, Juemin Fang, Yuanyuan Xiao, et al.. (2015). Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.. PubMed. 8(2). 2289–98. 14 indexed citations
13.
Guo, Xianling, Fei Hu, Shanshan Zhang, et al.. (2014). Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy. Cancer Letters. 346(2). 278–284. 34 indexed citations
14.
Fang, Juemin, Li Chu, Chunyan Li, et al.. (2014). JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway. Oncology Reports. 33(1). 494–502. 32 indexed citations
15.
Chen, Yijing, Fei Hu, Chunyan Li, et al.. (2013). The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis. Biomarkers. 19(1). 56–62. 21 indexed citations
16.
Guo, Xianling, Ding Li, Fei Hu, et al.. (2012). Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Letters. 320(2). 171–179. 158 indexed citations
17.
18.
Hu, Fei, et al.. (2010). Development of Hybrid Electric Vehicle Control System Based on V-Cycle. Applied Mechanics and Materials. 29-32. 918–922. 2 indexed citations
19.
Shang, Xifu, et al.. (2010). [Total hip replacement with collum femoris preserving for the treatment of advanced stage of femoral head necrosis of young patients: a report of results of more than five years follow-up].. PubMed. 48(17). 1298–300. 3 indexed citations
20.
Hai-yan, Xiong, Xianling Guo, Xinxin Bu, et al.. (2009). Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cell. Cancer Letters. 288(1). 68–74. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guanwu Li Breakdown of academic impact, for papers by Qiaoxia Zhang Breakdown of academic impact, for papers by Guangjie Yang Breakdown of academic impact, for papers by Chengwu Tang Breakdown of academic impact, for papers by Xiaoxiao Peng Breakdown of academic impact, for papers by Huijin Li Breakdown of academic impact, for papers by Qidong Li Breakdown of academic impact, for papers by Yawen Guo Breakdown of academic impact, for papers by Yingying Li
Rankless by CCL
2026